Shares of ANGLE plc (LON:AGL – Get Rating) passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 48.60 ($0.59) and traded as low as GBX 26.95 ($0.33). ANGLE shares last traded at GBX 30.50 ($0.37), with a volume of 11,580,353 shares changing hands.
Analysts Set New Price Targets
Separately, Berenberg Bank dropped their target price on shares of ANGLE from GBX 241 ($2.94) to GBX 120 ($1.46) and set a “buy” rating on the stock in a research report on Thursday, January 5th.
ANGLE Trading Up 4.4 %
The company’s 50-day moving average price is GBX 48.60 and its 200-day moving average price is GBX 63.26. The company has a quick ratio of 6.18, a current ratio of 6.55 and a debt-to-equity ratio of 16.43. The firm has a market cap of £83.00 million and a price-to-earnings ratio of -4.55.
ANGLE Company Profile
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD multiplex analysis system for routine and focused multiplex analysis of DNA, RNA or protein biomarkers.
- 3 Small-Cap Biopharma Stocks that Could See Big Growth in 2023
- Optimism About Global Demand For Metals Boosts BHP, Other Miners
- Exxon Mobil Expects Earnings and Cash Flow to Grow
- Sorrento Therapeutics, Scilex: 2 Hot Pharma Stocks On the Move
- Is The Great Alibaba Recovery About To Begin?
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.